46 related articles for article (PubMed ID: 27121317)
1. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144.
Cai H; Xue Y; Wang P; Wang Z; Li Z; Hu Y; Li Z; Shang X; Liu Y
Oncotarget; 2015 Aug; 6(23):19759-79. PubMed ID: 26078353
[TBL] [Abstract][Full Text] [Related]
2. Effect of caveolin-1 on the expression of tight junction-associated proteins in rat glioma-derived microvascular endothelial cells.
Li Y; Liu LB; Ma T; Wang P; Xue YX
Int J Clin Exp Pathol; 2015; 8(10):13067-74. PubMed ID: 26722502
[TBL] [Abstract][Full Text] [Related]
3. Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury.
Thal SC; Luh C; Schaible EV; Timaru-Kast R; Hedrich J; Luhmann HJ; Engelhard K; Zehendner CM
PLoS One; 2012; 7(12):e50752. PubMed ID: 23251381
[TBL] [Abstract][Full Text] [Related]
4. FXR1 stabilizes SNORD63 to regulate blood-tumor barrier permeability through SNORD63 mediated 2'-O-methylation of POU6F1.
Liang C; Zhai B; Wei D; Niu B; Ma J; Yao Y; Lin Y; Liu Y; Liu X; Wang P
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130642. PubMed ID: 38460644
[TBL] [Abstract][Full Text] [Related]
5. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.
Sarin H; Kanevsky AS; Wu H; Sousa AA; Wilson CM; Aronova MA; Griffiths GL; Leapman RD; Vo HQ
J Transl Med; 2009 Jun; 7():51. PubMed ID: 19549317
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract][Full Text] [Related]
7. Generation and identification of endothelial-specific Hrh2 knockout mice.
Meng R; Cai WK; Xu WM; Feng Q; Wang P; Huang YH; Fan YX; Zhou T; Yang Q; Li ZR; He GH
Transgenic Res; 2021 Jun; 30(3):251-261. PubMed ID: 33786748
[TBL] [Abstract][Full Text] [Related]
8. Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer.
Parodi A; Rudzińska M; Deviatkin AA; Soond SM; Baldin AV; Zamyatnin AA
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31137689
[TBL] [Abstract][Full Text] [Related]
9. Relationship between G proteins coupled receptors and tight junctions.
González-Mariscal L; Raya-Sandino A; González-González L; Hernández-Guzmán C
Tissue Barriers; 2018 Jan; 6(1):e1414015. PubMed ID: 29420165
[TBL] [Abstract][Full Text] [Related]
10. The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB.
Sa L; Li Y; Zhao L; Liu Y; Wang P; Liu L; Li Z; Ma J; Cai H; Xue Y
Front Mol Neurosci; 2017; 10():194. PubMed ID: 28701916
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
12. [Elucidation of New Function in Endothelial Cells for Efficient Delivery Strategy of Drug to Tissues].
Sakurai E
Yakugaku Zasshi; 2020; 140(1):51-62. PubMed ID: 31902886
[TBL] [Abstract][Full Text] [Related]
13. The blood-tumour barrier in cancer biology and therapy.
Steeg PS
Nat Rev Clin Oncol; 2021 Nov; 18(11):696-714. PubMed ID: 34253912
[TBL] [Abstract][Full Text] [Related]
14. The role of histamine in opening blood-tumor barrier.
Wang Z; Cai XJ; Qin J; Xie FJ; Han N; Lu HY
Oncotarget; 2016 May; 7(21):31299-310. PubMed ID: 27121317
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
